ENTITY
SMARTSCORE: 3.8/5
HilleVax

HilleVax (HLVX US)

8
Analysis
Health CareUnited States
HilleVax, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of novel vaccines. HilleVax operates in the United States.
more
bullishHilleVax
21 Apr 2022 10:21

HilleVax Pre-IPO: Lead Candidate Has Potential to Become First Approved Vaccine for Norovirus

Norovirus vaccine developer, Hillevax, formed by Takeda Pharmaceutical and PE firm Frazier Healthcare Partners, is seeking to raise up to $100...

Logo
553 Views
Share
x